A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Clinical trial NCT05439044 · COMPLETED

Trial details

NCT number: NCT05439044
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Study type: OBSERVATIONAL

Immunocompromised Patients

Start date: 2021-08-01
Primary completion: 2022-12-31
Enrollment: 4235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.